|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocn847526891 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130610s2012 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d E7B
|d OCLCQ
|d OCLCF
|d EBLCP
|d OCLCQ
|d AGLDB
|d OCLCQ
|d VTS
|d AU@
|d STF
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9781619426894
|q (electronic bk.)
|
020 |
|
|
|a 1619426897
|q (electronic bk.)
|
020 |
|
|
|z 9781619426818
|
020 |
|
|
|z 1619426811
|
029 |
1 |
|
|a AU@
|b 000062326074
|
029 |
1 |
|
|a DEBBG
|b BV043776348
|
029 |
1 |
|
|a DEBSZ
|b 472789090
|
035 |
|
|
|a (OCoLC)847526891
|
050 |
|
4 |
|a QP572.P4
|b G76 2012eb
|
072 |
|
7 |
|a SCI
|x 072000
|2 bisacsh
|
082 |
0 |
4 |
|a 571.8374
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Growth hormones :
|b synthesis, regulation & health implications /
|c edited by Anne Andersdtr, Jon Anderssen.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc.,
|c Ã2012.
|
300 |
|
|
|a 1 online resource (x, 170 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Endocrinology research and clinical developments
|
490 |
1 |
|
|a Metabolic diseases - laboratory and clinical research
|
504 |
|
|
|a Includes bibliographical references and index.
|
500 |
|
|
|a "Nova biomedical."
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; GROWTH HORMONES: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA; CONTENTS; PREFACE; Chapter 1: BIOTECH PLATFORM FOR DISCOVERY AND ASSESSMENT OF GROWTH HORMONES; 1. MODERN BIOTECHNOLOGY AND THE PRODUCTION OF PROTEIN HORMONES; 2. THE GROWTH HORMONE (GH) FAMILY; 3. GROWTH HORMONES OF ANIMAL ORIGIN; 4. BIOLOGICAL POTENTIAL OF GHS; 5. EXPRESSION SYSTEMS FOR GROWTH HORMONES; 6. TECHNOLOGICAL PLATFORM FOR CLONING GHS; 7. TECHNOLOGICAL PLATFORM FOR PRODUCING RECOMBINANT GHS.
|
505 |
8 |
|
|a 8. CONSTRUCTION OF GHS PRODUCING PICHIA PASTORIS STRAINS9. PRODUCTION AND ANALYSIS OF RECOMBINANT HORMONES IN ERLENMEYER FLASK; 10. PRODUCTION SCALING IN THE BIOREACTOR; 11. SEMIPURIFICATION OF RECOMBINANT HORMONES; 12. TESTING THE BIOLOGICAL ACTIVITY OF RECOMBINANT HORMONES; 13. CONTRIBUTIONS; 14. PERSPECTIVES; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: THEORETICAL APPROACHESTO GROWTH HORMONE SIGNALING; Abstract; 1. Introduction; 2. Mathematical Modeling of Ligand-Receptor Systems; 3. 1:1 Interaction Model; 4. 1:2 Symmetric Interaction Model; 5. 1:2 Symmetric and Sequential Interaction Model.
|
505 |
8 |
|
|a 6. 1:2 Asymmetric and Sequential Interaction Model7. Self-Antagonist Effect; 8. Enhanced Efficiency of GH Ligand Homodimers; 9. Receptor Monomer Versus Receptor Dimer Hypotheses; 10. Conclusion; 11. Acknowledgments; References; Chapter 3: EFFECT OF GROWTH HORMONE ON LIPID METABOLISM -- BASIC AND CLINICAL ASPECTS; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION; 2. GROWTH HORMONE: CHEMISTRY, GENE EXPRESSION AND SECRETION CONTROL; 3. GROWTH HORMONE RECEPTOR AND SIGNALING CASCADE; 4. EFFECTS OF GROWTH HORMONE ON LIPID METABOLISM IN THE ADIPOSE TISSUE, LIVER AND SKELETAL MUSCLE.
|
505 |
8 |
|
|a 5. STUDIES OF GROWTH HORMONE SECRETION AND ACTIONS IN HUMANS6. OBESITY, METABOLIC SYNDROME AND GROWTH HORMONE; 7. GROWTH HORMONE DEFICIENCY AND VISCERAL (TRUNCAL) OBESITY; 8. GROWTH HORMONE TREATMENT AND PERSPECTIVES; REFERENCES; Chapter 4: THE HUMAN GROWTH HORMONE: SYNTHESIS, REGULATION AND HEALTH IMPLICATIONS; ABSTRACT; I. INTRODUCTION; II. HGH SYNTHESIS AND REGULATION; III. BIOLOGICAL RELEVANCE AND IMPACT ON HEALTH; CONCLUSION; REFERENCES; Chapter 5: CIRCULATION CONCENTRATION OF ESTRADIOL, GROWTH HORMONE, INSULIN LIKE GROWTH FACTOR AFTER FOLLICLE ASPIRATION IN CATTLE; ABSTRACT.
|
505 |
8 |
|
|a 1. INTRODUCTION2. MATERIALS AND METHODS; 3. RESULT; 4. DISCUSSION; REFERENCES; Chapter 6: STABILITY STUDY OF SOMATROPIN BY CAPILLARY ZONE ELECTROPHORESIS; ABSTRACT; INTRODUCTION; EXPERIMENTAL; RESULTS AND DISCUSSION; CONCLUSION; REFERENCES; Chapter 7: CARDIAC EFFECTS OF GROWTH HORMONE TREATMENT IN PEDIATRIC POPULATIONS; INTRODUCTION; BACKGROUND; GROWTH HORMONE THERAPY IN THE CARDIAC SETTING; ISOLATED GH DEFICIENCY; TURNER SYNDROME; NOONAN SYNDROME; PRADER-WILLI SYNDROME; SMALL FOR GESTATIONAL AGE (SGA); INDUCED GH DEFICIENCY; CONCLUSION; REFERENCES.
|
505 |
8 |
|
|a Chapter 8: RECOMBINANT HUMAN GROWTH HORMONE TREATMENT IN PATIENTS WITH GROWTH DEFICIENCY AND CROHN'S DISEASE -- NEW PERSPECTIVES.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Peptide hormones.
|
650 |
|
0 |
|a Somatotropin.
|
650 |
|
6 |
|a Hormones peptidiques.
|
650 |
|
6 |
|a Somatotrophine.
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Developmental Biology.
|2 bisacsh
|
650 |
|
7 |
|a Peptide hormones
|2 fast
|
650 |
|
7 |
|a Somatotropin
|2 fast
|
700 |
1 |
|
|a Andersdtr, Anne,
|e editor.
|
700 |
1 |
|
|a Anderssen, Jon,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Growth hormones
|z 9781619426818
|w (OCoLC)800860818
|
830 |
|
0 |
|a Endocrinology research and clinical developments.
|
830 |
|
0 |
|a Metabolic diseases--laboratory and clinical research series.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=591918
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3022450
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10719448
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 591918
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7422641
|
994 |
|
|
|a 92
|b IZTAP
|